NYSE:FMS Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price & News $22.27 +0.35 (+1.60%) (As of 04:00 PM ET) Add Compare Share Share Today's Range$22.08▼$22.2850-Day Range$20.64▼$24.5452-Week Range$12.78▼$29.14Volume309,634 shsAverage Volume795,164 shsMarket Capitalization$13.07 billionP/E Ratio21.01Dividend Yield1.89%Price Target$28.45 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Fresenius Medical Care AG & Co. KGaA MarketRank™ ForecastAnalyst RatingHold1.78 Rating ScoreUpside/Downside27.9% Upside$28.45 Price TargetShort InterestHealthy0.26% of Shares Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews Sentiment1.33Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth29.31%From $1.16 to $1.50 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.02 out of 5 starsMedical Sector22nd out of 984 stocksMiscellaneous Health & Allied Services, Not Elsewhere Classified Industry1st out of 8 stocks 2.9 Analyst's Opinion Consensus RatingFresenius Medical Care AG & Co. KGaA has received a consensus rating of Hold. The company's average rating score is 1.78, and is based on no buy ratings, 7 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $28.45, Fresenius Medical Care AG & Co. KGaA has a forecasted upside of 27.9% from its current price of $22.24.Amount of Analyst CoverageFresenius Medical Care AG & Co. KGaA has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.26% of the outstanding shares of Fresenius Medical Care AG & Co. KGaA have been sold short.Short Interest Ratio / Days to CoverFresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fresenius Medical Care AG & Co. KGaA has recently decreased by 7.93%, indicating that investor sentiment is improving significantly. Previous Next 2.5 Dividend Strength Dividend YieldFresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 1.90%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthFresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 39.62%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 28.00% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FMS. Previous Next 3.5 News and Social Media Coverage News SentimentFresenius Medical Care AG & Co. KGaA has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Fresenius Medical Care AG & Co. KGaA this week, compared to 2 articles on an average week.Search Interest5 people have searched for FMS on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 5.56% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions. Previous Next 3.8 Earnings and Valuation Earnings GrowthEarnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 29.31% in the coming year, from $1.16 to $1.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 20.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.25.Price to Earnings Ratio vs. SectorThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 20.98, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.51.Price to Book Value per Share RatioFresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) StockFresenius Medical Care AG & Co. KgaA engages in the provision of products and services for individuals with renal diseases of which regularly undergo dialysis treatment. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the healthcare services business. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.Read More Receive FMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address FMS Stock News HeadlinesJune 2, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Now Covered by Analysts at StockNews.comJune 1, 2023 | msn.comFresenius Medical Care: Other Stocks Still Better, But Upside ExistsJune 6, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 27, 2023 | americanbankingnews.comZacks Research Analysts Cut Earnings Estimates for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)May 26, 2023 | americanbankingnews.comQ2 2024 EPS Estimates for Fresenius Medical Care AG & Co. KGaA Increased by Analyst (NYSE:FMS)May 23, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives $29.37 Consensus Target Price from AnalystsMay 16, 2023 | insidermonkey.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2023 Earnings Call TranscriptMay 15, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (FMS) to Issue Annual Dividend of $0.71 on June 1stJune 6, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 10, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives New Coverage from Analysts at StockNews.comMay 10, 2023 | finance.yahoo.comFresenius Medical Care AG & Co. KGaA: Fresenius Medical Care Earnings: Good Start to Year as External Pressures EaseMay 9, 2023 | reuters.comFresenius Medical Care's operating profit down 9%April 29, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Rating Upgraded by Deutsche Bank AktiengesellschaftApril 28, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives $28.45 Average Target Price from AnalystsApril 22, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Gap Down to $22.38April 19, 2023 | finance.yahoo.comFresenius Medical Care AG & Co. KGaA: Fresenius Medical Care: 2025 Margin Aspirations Depend on Medtech SegmentApril 16, 2023 | americanbankingnews.comTruist Financial Boosts Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Price Target to $24.00April 16, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Gap Up Following Analyst UpgradeApril 14, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Price Target Raised to $24.00 at Truist FinancialApril 14, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Volume IncreaseApril 3, 2023 | americanbankingnews.comFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives $28.20 Average Price Target from BrokeragesMarch 22, 2023 | finance.yahoo.comInnovative Home Dialysis Training Unit Opens at Indianapolis Fresenius Kidney Care LocationMarch 21, 2023 | seekingalpha.comFresenius Medical Care: Attractive Post Crash, Maintaining A 'Buy' RatingMarch 6, 2023 | finance.yahoo.comFresenius Kidney Care Renews Commitment to Kidney Health Education with Second Year Boys & Girls Clubs of America National PartnershipFebruary 24, 2023 | finance.yahoo.comEarnings Update: Fresenius Medical Care AG & Co. KGaA (ETR:FME) Just Reported Its Full-Year Results And Analysts Are Updating Their ForecastsFebruary 22, 2023 | news.yahoo.comFMC boosted by Fresenius plan to cede control but keep stakeFebruary 21, 2023 | finance.yahoo.comGermany's Fresenius to simplify structure, flags potential profit fallSee More Headlines FMS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FMS Company Calendar Last Earnings11/02/2021Ex-Dividend for 6/1 Dividend5/17/2023Dividend Payable6/01/2023Today6/06/2023Next Earnings (Estimated)7/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNYSE:FMS CUSIPN/A CIK1333141 Webwww.freseniusmedicalcare.com Phone(496) 172-6090Fax49-6172-609-2301Employees1,235Year Founded1912Price Target and Rating Average Stock Price Forecast$28.45 High Stock Price Forecast$51.80 Low Stock Price Forecast$11.70 Forecasted Upside/Downside+28.4%Consensus RatingHold Rating Score (0-4)1.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$1.06 Trailing P/E Ratio20.90 Forward P/E Ratio19.09 P/E GrowthN/ANet Income$709.50 million Net Margins3.06% Pretax Margin5.72% Return on Equity5.44% Return on Assets2.35% Debt Debt-to-Equity Ratio0.48 Current Ratio1.32 Quick Ratio0.96 Sales & Book Value Annual Sales$20.44 billion Price / Sales0.64 Cash Flow$5.01 per share Price / Cash Flow4.42 Book Value$27.74 per share Price / Book0.80Miscellaneous Outstanding Shares586,830,000Free FloatN/AMarket Cap$13.00 billion OptionableOptionable Beta1.02 Social Links Key ExecutivesHelen GizaChief Executive & Financial OfficerFranklin W. MadduxGlobal Chief Medical OfficerDominik HegerSenior VP, Head-IR & Corporate CommunicationsWilliam ValleChief Executive Officer-North AmericaKatarzyna Mazur-HofsaessChief Executive Officer-Care EnablementKey Competitorsagilon healthNYSE:AGLDaVitaNYSE:DVASotera HealthNASDAQ:SHCProgynyNASDAQ:PGNYSmith & NephewNYSE:SNNView All CompetitorsInstitutional OwnershipEP Wealth Advisors LLCBought 2,860 shares on 6/5/2023Ownership: 0.000%Toroso Investments LLCBought 11,227 shares on 5/23/2023Ownership: 0.002%Ameriprise Financial Inc.Bought 2,232 shares on 5/22/2023Ownership: 0.004%JPMorgan Chase & Co.Bought 2,861 shares on 5/18/2023Ownership: 0.001%Quilter PlcBought 1,694 shares on 5/16/2023Ownership: 0.000%View All Institutional Transactions FMS Stock - Frequently Asked Questions Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 2 sell ratings and 7 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares. View FMS analyst ratings or view top-rated stocks. What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023? 9 equities research analysts have issued 12-month price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $11.70 to $51.80. On average, they predict the company's share price to reach $28.45 in the next twelve months. This suggests a possible upside of 28.4% from the stock's current price. View analysts price targets for FMS or view top-rated stocks among Wall Street analysts. How have FMS shares performed in 2023? Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 at the beginning of 2023. Since then, FMS stock has increased by 35.6% and is now trading at $22.15. View the best growth stocks for 2023 here. Are investors shorting Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 1,510,000 shares, a decrease of 7.9% from the April 30th total of 1,640,000 shares. Based on an average daily volume of 900,300 shares, the short-interest ratio is currently 1.7 days. View Fresenius Medical Care AG & Co. KGaA's Short Interest. When is Fresenius Medical Care AG & Co. KGaA's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023. View our FMS earnings forecast. How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) issued its earnings results on Tuesday, November, 2nd. The company reported $0.55 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.55. The business earned $5.24 billion during the quarter, compared to analysts' expectations of $5.37 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 5.44% and a net margin of 3.06%. How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Wednesday, May 3rd. Shareholders of record on Thursday, May 18th will be paid a dividend of $0.7086 per share on Thursday, June 1st. This represents a dividend yield of 2.1%. The ex-dividend date is Wednesday, May 17th. Read our dividend analysis for FMS. What ETFs hold Fresenius Medical Care AG & Co. KGaA's stock? ETFs with the largest weight of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) stock in their portfolio include Invesco International Dividend Achievers ETF (PID), Cultivar ETF (CVAR), Pacer Global Cash Cows Dividend ETF (GCOW) and Pacer Trendpilot European Index ETF (PTEU).Avantis Responsible International Equity ETF (AVSD), Is Fresenius Medical Care AG & Co. KGaA a good dividend stock? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 1.90%. The dividend payout ratio is 39.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 28.00% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for FMS. What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F). What is Fresenius Medical Care AG & Co. KGaA's stock symbol? Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS." Who are Fresenius Medical Care AG & Co. KGaA's major shareholders? Fresenius Medical Care AG & Co. KGaA's stock is owned by many different retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (3.41%), Dodge & Cox (0.72%), Balyasny Asset Management L.P. (0.13%), Arrowstreet Capital Limited Partnership (0.12%), BlackRock Inc. (0.08%) and Two Sigma Advisers LP (0.04%). How do I buy shares of Fresenius Medical Care AG & Co. KGaA? Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Fresenius Medical Care AG & Co. KGaA's stock price today? One share of FMS stock can currently be purchased for approximately $22.15. How much money does Fresenius Medical Care AG & Co. KGaA make? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $13.00 billion and generates $20.44 billion in revenue each year. The company earns $709.50 million in net income (profit) each year or $1.06 on an earnings per share basis. How many employees does Fresenius Medical Care AG & Co. KGaA have? The company employs 1,235 workers across the globe. Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries? The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.Read More How can I contact Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301. This page (NYSE:FMS) was last updated on 6/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.